` DIGP (Digipath Inc) vs S&P 500 Comparison - Alpha Spread

DIGP
vs
S&P 500

Over the past 12 months, DIGP has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +12% growth.

Stocks Performance
DIGP vs S&P 500

Loading
DIGP
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
DIGP vs S&P 500

Performance Gap Between DIGP and GSPC
HIDDEN
Show

Performance By Year
DIGP vs S&P 500

Loading
DIGP
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Digipath Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Digipath Inc
Glance View

Market Cap
3.4m USD
Industry
Health Care

DigiPath, Inc. engages in the provision of cannabis testing, education, training, and news coverage. The company is headquartered in Las Vegas, Nevada. The company went IPO on 2011-12-23. The Company’s cannabis testing business is operated through its subsidiary, Digipath Labs, Inc., which performs all cannabis related testing using FDA-compliant laboratory equipment and processes. The firm is a third-party independent testing laboratory facility for cannabis, cannabis infused products, hemp and other botanical nutraceuticals to serve growers, dispensaries, caregivers, producers, patients and eventually all end users of cannabis and botanical products. Its Digipath Labs screens medicinal and recreational cannabis for harmful contaminants, including residual solvents, moisture, water activity, visual inspection, pesticides, heavy metals, biological toxins and microbial contaminants.

DIGP Intrinsic Value
Not Available
Back to Top